First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable of unfavorable early stage Hodgkin's lymphoma (HL)

Reviewer: Ryan Smith , MD
Ultima Vez Modificado: 14 de mayo del 2005

Translation for this article does not exist


Catherine and Finn
by OncoLink Editorial Team
December 01, 2015